NEW DELHI: The Mauritius-based WestBridge capital Partners on Tuesday announced acquisition of 26 per cent stake in Dr Lal PathLabs, according to a company release. However, no investment figures were made available by the company.
WestBridge is a Mauritius-based US-India focussed fund with a corpus of around $140 million. The fund focuses primarily on services companies.
Dr Lal PathLabs is on of the largest domestic diagnostic companies running clinical pathology laboratory chains through the franchisee route and has recorded strong growths during the last five years.